|
Market Closed -
Nasdaq
16:00:00 2026-09-10 EDT
|
5-day change | 1st Jan Change | ||
| 7.720 USD | -4.22% |
|
-5.74% | +289.90% |
| 08-10 | ImmunityBio, Inc. Announces Appointment of Dr. Jim Yong Kim as Vice Chairman | CI |
| 08-04 | ImmunityBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 8.18B 7.04B 6.64B 6.05B 11.31B 782B 11.41B 79.07B 30.43B 397B 30.72B 30.05B 1,260B | P/E 2026 * |
-8.04x | P/E 2027 * | -54.2x |
|---|---|---|---|---|---|
| Enterprise Value | 8.18B 7.04B 6.64B 6.05B 11.31B 782B 11.41B 79.07B 30.43B 397B 30.72B 30.05B 1,260B | EV / Sales 2026 * |
36.2x | EV / Sales 2027 * | 18.5x |
| Free-Float |
37.83% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IBRX | Delayed | |
CBOE
| IBRX | Real-time | |
|
Tradegate
| 26CA | Real-time | |
|
Boerse Muenchen
| 26CA | Real-time | |
|
Börse Stuttgart
| 26CA | Delayed | |
|
Deutsche Boerse AG
| 26CA | Delayed | |
|
Xetra
| 26CA | Delayed |
Last Transcript : ImmunityBio, Inc.
| 1 day | +1.17% | ||
| 1 week | -5.74% | ||
| Current month | -2.89% | ||
| 1 month | +3.07% | ||
| 3 months | +10.60% | ||
| 6 months | -3.62% | ||
| Current year | +289.90% |
| 1 week | 7.64 |  | 8.37 |
| 1 month | 7.43 | | 8.76 |
| Current year | 1.98 | | 12.43 |
| 1 year | 1.95 | | 12.43 |
| 3 years | 1.25 | | 12.43 |
| 5 years | 1.21 | | 12.43 |
| 10 years | 1.21 | | 40.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 57 | 2020-09-30 |
| Chief Executive Officer | 73 | 2015-02-28 | |
David Sachs
DFI | Director of Finance/CFO | 48 | 2021-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Wesley Clark
BRD | Director/Board Member | 80 | 2021-01-31 |
| Director/Board Member | 71 | 2021-02-28 | |
| Chairman | 73 | 2014-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/26 | Exercice | Director | 243,168 | 0.0232% | ||
| 7/1/26 | Exercice | Director | 478,434 | 0.0457% | ||
| 6/30/26 | Exercice | Director | 3,000 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.22% | -5.74% | +200.39% | +498.45% | 8.54B | |
| -0.25% | -1.36% | +44.08% | +102.76% | 68.52B | |
| -1.09% | -6.20% | +30.50% | +76.56% | 62.88B | |
| -1.18% | +0.47% | -12.78% | +384.69% | 28.13B | |
| -1.47% | -4.84% | +30.00% | +9.60% | 25.56B | |
| -1.76% | -6.30% | -4.55% | -19.75% | 24.65B | |
| -2.39% | -5.19% | +17.75% | -20.95% | 19.81B | |
| -1.86% | -2.22% | +202.03% | +353.89% | 17.69B | |
| -2.07% | -5.07% | -5.42% | +494.88% | 14.66B | |
| -1.54% | -2.88% | +52.33% | +159.75% | 14.45B | |
| Average | -1.24% | -1.66% | +55.43% | +203.99% | 28.49B | |
| Weighted average by Cap. | -1.13% | -2.08% | +40.53% | +147.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 226M 194M 183M 167M 312M 21.58B 315M 2.18B 840M 10.95B 848M 829M 34.77B | 441M 380M 358M 326M 610M 42.21B 616M 4.27B 1.64B 21.41B 1.66B 1.62B 68B |
| Net income | -1B -864M -815M -742M -1.39B -96B -1.4B -9.7B -3.73B -48.69B -3.77B -3.69B -155B | -150M -129M -122M -111M -208M -14.37B -210M -1.45B -559M -7.29B -564M -552M -23.15B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-10 | US$7.720 | -4.22% | 8,805,734 |
| 26-09-09 | US$8.060 | -2.77% | 9,488,937 |
| 26-09-08 | US$8.290 | +2.60% | 7,741,308 |
| 26-09-04 | US$8.080 | -1.34% | 4,330,218 |
| 26-09-03 | US$8.190 | +3.02% | 5,271,763 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IBRX Stock
Select your edition
All financial news and data tailored to specific country editions
